Hims & Hers Health (HIMS) EBT Margin Growth (1y) (2021 - 2026)

Hims & Hers Health (HIMS) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 342.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -166.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1,258.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -1,049.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2,773.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 132.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -16,509.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -2,702.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1,555.00
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 127,245.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,702.00
Dec 31, 2025 -166.00
Sep 30, 2025 -383.00
Jun 30, 2025 178.00
Mar 31, 2025 586.00
Dec 31, 2024 374.00
Sep 30, 2024 893.00
Jun 30, 2024 770.00
Mar 31, 2024 953.00
Dec 31, 2023 749.00
Sep 30, 2023 997.00
Jun 30, 2023 1,387.00
Mar 31, 2023 1,087.00
Dec 31, 2022 3,030.00
Sep 30, 2022 1,275.00
Jun 30, 2022 -229.00
Mar 31, 2022 8,214.00
Dec 31, 2021 -2,434.00
Sep 30, 2021 -1,164.00
Jun 30, 2021 -1,240.00